Aprea Therapeutics Inc

Aprea Therapeutics Inc(APRE)價格預測

$0.528

+0.035 (+6.60%)收盤時

價格預測

1-Day Price Prediction
-1.10%
1-Week Prediction
-2.25%
1-Month Prediction
—
2026 Prediction
—
2030 Prediction
—

在 App 中開啟以解鎖更長週期的預測。

Loading chart…

APRE 相似圖表分析預測

Alphio's APRE stock price prediction model matches the current Aprea Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.52 (-1.10%). The 1-week path is $0.52 (-2.25%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

該買進 Aprea Therapeutics Inc 股票嗎?

Aprea Therapeutics Inc is a good buy right now due to its recent price increase of 8.96% over the last five days, indicating positive momentum. The stock's current price is $0.53, which is significantly below its 52-week high of $1.49, suggesting potential for upside. Additionally, the company has a strong cash position of $46.5 million as of March 31, 2026, which is expected to sustain operations until Q1 2028, reducing financial risk. However, the main risk is the ongoing negative earnings trend, with a reported EPS of -0.09 in the last quarter, which reflects continued losses.

APRE 股價於 Friday 收在 $0.53,此前上漲 +6.60%

Aprea Therapeutics Inc (APRE) last closed at $0.528, gaining +6.60%. These facts feed the 1-day and 1-week APRE price prediction above.

預測驅動因素

Aprea Therapeutics Inc(APRE)的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Negative

Bearish

SMA 200

Negative

Bearish

相似圖表形態

近期走勢與 APRE 最接近的股票,依相似度排序。

APRE 季節性分析

Historically the probability of a positive November return for APRE is 0.00%. January offers the highest probability of a positive month at 80.33%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易